Professor Utkan Demirci
Interim Division Chief and Director, Stanford Canary Center for Early Cancer Detection
Professor of Radiology
Professor of Electrical Engineering (by Courtesy)
Stanford University, USA
Email: [email protected]
Utkan Demirci is a professor with tenure at Stanford University School of Medicine and serves as the interim division chief and director of the Canary Center for Cancer Early Detection in the Department of Radiology. Prior to this appointment, he was an Associate Professor of Medicine at the Brigham and Women’s Hospital, Harvard Medical School. He also served as a faculty at the Harvard-MIT Health Sciences and Technology division. His group focuses on developing innovative microfluidic biomedical technology platforms with broad applications to multiple diseases. Some of his inventions have already been translated into Food and Drug Administration-approved products serving patients. He has mentored and trained many successful scientists, entrepreneurs and academicians.
Professor Supriyo Datta
Thomas Duncan Distinguished Professor of Electrical and Computer Engineering
School of Electrical Engineering
Purdue University, USA
Email: [email protected]
Supriyo Datta received his PhD from University of Illinois at Urbana-Champaign and has been with Purdue University since 1981. The non-equilibrium Green function (NEGF) method approach pioneered by his group for the description of quantum transport has been widely adopted in the field of nanoelectronics and he was elected to the US National Academy of Engineering for this work. He is also known for innovative theoretical proposals that have inspired new fields of research including molecular thermoelectricity, negative capacitance devices, and spintronics.
We are proud to have been chosen to lead this exciting opportunity for the greater community of applied researchers, applied scientists and engineers worldwide, namely the development of new high-impact journal entitled "Innovation and Emerging Technologies" (formerly known as TECHNOLOGY).
The motivation for this endeavor is to address the growing frustration among many applied scientists and engineers, who wish to publish their pioneering work in high-impact, interdisciplinary journals. High visibility/ high impact journals, in general, focus on the structure and function of the underlying science, and see technology development and technological innovation as less important. This focus has historically rejected many a Nobel Laureate's critical paper (e.g. Yalow and Berson's Radioimmunoassay, Paul Lautebur's NMR/MRI work, Kary Mullis' PCR paper, just to name a few). Certain clinical journals do provide high impact, but only after all the translational issues have been resolved to fully realize the application in patients. This "Catch-22" plagues applied scientists and engineers in all of today's important disciplines, but especially those working in the fields related to the Life and Health Science and Technology.
This limitation also has a negative impact on the entire process of research transfer and commercialization (or research translation). Such transfer of new, innovative technological ideas is best served by a proper means of publication of the initial scientific breakthrough, where the proof of concept is established and the actual innovation occurs and proceeds. Publication of these important advances tend, in our opinion, to suffer from, on the one hand, non-appreciative policies by the above-mentioned high impact science journals, and on the other hand, from the fact that somewhat less desirable, lower impact journals typically fail to garner adequate attention, and often lead to a lack of adequate funding. The resulting consequences of both constitute a virtual graveyard where many truly innovative ideas are buried.
In response to these growing concerns, which we know many of our esteemed international colleagues share, we are delighted to announce a new, high impact-striving yet inclusive by definition journal, called Innovation and Emerging Technologies. In this new journal, we aim to capture all work that is innovative, enabling, transformative, and early in its development with adequate proof of concept. We wish to emphasize the technology and its impact, and are not necessarily concerned if the paper is not "hypothesis driven".
Our publishing partner, World Scientific (WSPC) is fiercely dedicated to making the new Innovation and Emerging Technologies journal attain, a high impact factor as soon as possible, an effort which both of us and our colleagues on the Editorial Board intend to support wholeheartedly. This, of course, includes a very aggressive marketing and outreach plan. In this respect, we feel that the global reach and operation of ICP / WSPC, with their special strength in Asian Emerging markets, many of which have become hotbeds of innovation and new technological ideas, make this journal endeavor especially exciting.
Professor Martin "Maish" Yarmush
Founding Director, Center for Engineering in Medicine Harvard Medical School/Massachusetts General Hospital Paul and Mary Monroe Professor of Science and Engineering Distinguished Professor of Biomedical Engineering Rutgers University
Professor Mehmet Toner
Founding Director, NIH BioMEMs Resource Center Harvard Medical School/Massachusetts General Hospital Helen Andrus Benedict Professor of Surgery and Bioengineering Harvard-MIT Division of Health Sciences and Technology Harvard Medical School
We have a truly exciting opportunity to announce to the greater community of applied researchers, applied scientists and engineers worldwide. We are launching a new high-impact-striving journal entitled "Innovation and Emerging Technologies"